See how SK hynix Inc. and AbbVie Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1,238.35
KSE
SK hynix Inc. is a South Korean semiconductor company and one of the world’s largest producers of memory chips. Its core products include DRAM and NAND flash memory used in data centers, personal computers, smartphones, servers, and artificial intelligence infrastructure. The company plays an important role in the global supply chain for advanced computing, with demand tied closely to cloud services, enterprise hardware, mobile devices, and high-performance AI systems.
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.